NIH-funded research R21 grant

Investigating brain fog in COVID-19 survivors

Official title: Glial activation and metabolite contributions to 'brain fog' post-acute sequelae of COVID-19 (PASC)

Funded at Massachusetts General Hospital · NIH-10890187 · Data updated 2026-11-12

This study is looking at the brain fog some people feel after recovering from COVID-19, and it’s for those who want to understand why they might be having trouble with thinking and focus; participants will have brain scans while doing tasks to help researchers learn more about what's happening in their brains.

More COVID-19 research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$208,750
NIH project number5R21NS130283-02
Project IDNIH-10890187 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals under 21 years old who have experienced cognitive symptoms after recovering from COVID-19.

Less likely to help

Patients who have not had COVID-19 or do not experience cognitive symptoms related to PASC may not benefit from this research.

What this research studies

This research focuses on understanding the cognitive difficulties, often referred to as 'brain fog', experienced by individuals who have recovered from COVID-19. By using advanced neuroimaging techniques, the study aims to measure brain activity and inflammation in specific brain regions during cognitive tasks. Participants will undergo MRI-PET scans while performing tasks designed to assess their cognitive control and attention. The goal is to identify the biological factors contributing to these cognitive symptoms in post-acute sequelae of COVID-19 (PASC).

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for cognitive impairments in COVID-19 survivors.

How similar studies have gone: Other research has shown promising results in understanding cognitive symptoms related to inflammation, making this approach both relevant and potentially impactful.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Vanelzakker, Michael B — Massachusetts General Hospital
  • Study coordinator: Vanelzakker, Michael B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.